Home » Generic-Drug Makers May Remove REMS Under Final FDA Guidance
Generic-Drug Makers May Remove REMS Under Final FDA Guidance
A final FDA guidance allows generic-drug makers to remove a drug’s risk evaluation and mitigation strategy (REMS) if the reference drug’s REMS has been removed.
Generic Line
Generic Line
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May